ARCHIVES

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

This article is from The Cancer Letter archive.

Vol. 34 No. 31 | August 8, 2008

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

‘Meta-analysis’ Of Early Breast Cancer Trials finds Adjuvant Therapy Significantly Prolongs Life

January 10, 1992

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980

NCI Payline To Jump To 25th Percentile For A Portion Of Grants, Director Says

April 24, 2009

Frei, Freireich Share One GM Prize; Ames, Erikson Win Others

June 17, 1983